Michael M. Derkacz

Amministratore Delegato presso BRAEBURN INC.

56 anni

Health Technology

Consumer Services

Commercial Services

Posizioni attive di Michael M. Derkacz

Società	Posizione	Inizio	Fine
BRAEBURN INC.	Direttore/Membro del Consiglio	05/06/2017	-
	Amministratore Delegato	05/06/2017	-
	Presidente	05/06/2017	-

Società	Posizione	Inizio	Fine
AUSPEX PHARMACEUTICALS INC	Corporate Officer/Principal	05/05/2015	-
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Corporate Officer/Principal	-	-
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	01/01/2011	-

The University of Texas at Austin

Undergraduate Degree

Distribuzione geografica

Stati Uniti	5
Israele	2

Posizioni

Corporate Officer/Principal	3
Undergraduate Degree	1
Director/Board Member	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Health Technology

Aziende private	3
Auspex Pharmaceuticals, Inc. Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA.	Health Technology
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Health Technology
Braeburn, Inc. Braeburn, Inc. Miscellaneous Commercial ServicesCommercial Services Braeburn, Inc. manufactures pharmaceutical products. It focuses on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain and schizophrenia. The firm develops Probuphine for the treatment of adult patients with opioid dependence. The company was founded in 2012 and is headquartered in Princeton, NJ.	Commercial Services